Clinical Laserthermia Systems AB (publ) (CLS-B) — Working Capital to Net Assets Ratio
Clinical Laserthermia Systems AB (publ) (CLS-B) has a Working Capital to Net Assets ratio of 33.0% as of March 2026. Working capital of Skr18.96 Million (current assets of Skr28.89 Million minus current liabilities of Skr9.92 Million) is measured against net assets of Skr57.52 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See financial flexibility index of Clinical Laserthermia Systems AB (publ) to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Clinical Laserthermia Systems AB (publ) Working Capital to Net Assets (2008–2025)
This chart shows how Clinical Laserthermia Systems AB (publ)'s Working Capital to Net Assets ratio has evolved across 18 annual periods from 2008 to 2025. As of March 2026, the ratio stands at 33.0%, reflecting working capital of Skr18.96 Million against net assets of Skr57.52 Million SEK. See how many days can Clinical Laserthermia Systems AB (publ) fund operations to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Clinical Laserthermia Systems AB (publ) (2008–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Clinical Laserthermia Systems AB (publ) from 2008 to 2025, covering 18 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Clinical Laserthermia Systems AB (publ) (CLS-B) total market value.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 43.8% | Skr29.12 Million | Skr66.48 Million | Skr39.12 Million | Skr10.00 Million | ▲ +4.9 pp |
| 2024 | 38.9% | Skr25.54 Million | Skr65.69 Million | Skr38.41 Million | Skr12.87 Million | ▲ +8.6 pp |
| 2023 | 30.3% | Skr13.17 Million | Skr43.53 Million | Skr27.14 Million | Skr13.97 Million | ▲ +251.2 pp |
| 2022 | -220.9% | Skr-17.38 Million | Skr7.87 Million | Skr24.26 Million | Skr41.64 Million | ▼ -206.6 pp |
| 2021 | -14.3% | Skr-3.03 Million | Skr21.18 Million | Skr42.42 Million | Skr45.45 Million | ▲ +51.3 pp |
| 2020 | -65.6% | Skr-9.13 Million | Skr13.93 Million | Skr20.90 Million | Skr30.03 Million | ▲ +199.0 pp |
| 2019 | -264.6% | Skr-18.51 Million | Skr7.00 Million | Skr12.55 Million | Skr31.06 Million | ▼ -313.0 pp |
| 2018 | 48.4% | Skr24.09 Million | Skr49.81 Million | Skr31.30 Million | Skr7.21 Million | ▲ +18.5 pp |
| 2017 | 29.9% | Skr9.85 Million | Skr33.00 Million | Skr20.40 Million | Skr10.54 Million | ▲ +47.3 pp |
| 2016 | -17.5% | Skr-2.98 Million | Skr17.06 Million | Skr7.26 Million | Skr10.24 Million | ▼ -22.1 pp |
| 2015 | 4.6% | Skr901.59K | Skr19.46 Million | Skr3.71 Million | Skr2.81 Million | ▼ -42.4 pp |
| 2014 | 47.1% | Skr14.86 Million | Skr31.58 Million | Skr20.24 Million | Skr5.38 Million | ▲ +1.8 pp |
| 2013 | 45.3% | Skr11.81 Million | Skr26.09 Million | Skr14.84 Million | Skr3.04 Million | ▲ +15.2 pp |
| 2012 | 30.1% | Skr5.14 Million | Skr17.09 Million | Skr8.04 Million | Skr2.89 Million | ▲ +21.9 pp |
| 2011 | 8.2% | Skr890.04K | Skr10.83 Million | Skr2.92 Million | Skr2.03 Million | ▼ -13.0 pp |
| 2010 | 21.2% | Skr2.19 Million | Skr10.36 Million | Skr3.39 Million | Skr1.20 Million | ▲ +11.1 pp |
| 2009 | 10.1% | Skr667.09K | Skr6.63 Million | Skr1.65 Million | Skr983.65K | ▼ -22.1 pp |
| 2008 | 32.2% | Skr1.18 Million | Skr3.68 Million | Skr2.23 Million | Skr1.05 Million | — |